A prospective, randomized, controlled study of warfarin plus aspirin to prevent coronary reocclusion after thrombolysis  by Melandri, Giovanni et al.
JACC February 1996 ABSTRACTS-PostcT 249A 
Conclusions: In a pattern population aggressively treated to reopen the 
infamt related vessel, addition of an angietensin converting enzyme inhibitor 
only influenced the process of infarct expansion and remodelling in patients 
with a severe residual stenosis in the coronary artery. 
97~'~'~-62] Thrombolyl ic  Therapy Can Be Given to Half of  
- Hospitalized PatIsnts With Acute Myocardial 
Infarction 
Christopher J. Ellis, John K. French, Barbara F. Williams, Susan Wyatt, 
June Poole, Christina Ingrain, Miles G. Williams, Hamlsh H. Hart, Harvey 
D. White. Green Lane Hospital, Auckland, New Zealand 
Despite the proven benefits of thrembelytic therapy (I"I"), only a minority of 
patients (lots) receive it (35% in the recently reported USA National Registry). 
We prospectively recorded the number of pfa eligible to receive 1"I" when 
admitted in 1993 from a I million catchment population (4 coronary care 
units, no age limits). 
Eligibility was based on ECG cdloda: > 2 mm ST elevation in leads V 1-3, > 
I mm ST elevation in any other 2 contiguous leads, or now onset of left bundle 
branch block with symptom onset within 12 hours and no contraledlcationo 
to "IT. We defined 'definite' myocardial infarction (~I) us 2 of: >_ 20 rains 
ischemlo chest pain, peak CK > 600 u/L (x 2 normal), presence of Q ~veves; 
'probable' MI as CK 300-600 u/L; 'aborted MI' as ST elevation given TT but 
with no CK dse. Over I year there were 1081 pts with 'definite' (n = 948), 
'probable' (n = 124), or 'aborted' (n = 9) Mls. 
53% (576/1081) pts were ECG edteda and time (< 12 hours) TT eligible, 
but 47 pts were 1"I" ineligible because of bleeding risk (39 detinite, 8 relative 
contralndications). Hence 49% (529/1081 ~of pts were actually TT eligible, of 
whom 470 (89%) wore., given TT. Overall hospital mortality for TT elig~le pts 
was 12.7% (11,7°/, if TT treated, 17.0% if not TT treated), 
Condusion: With standard criteria for TT, half of hospitalized pts with a 
discharge diagnos!s of MI are eligible for treatment at admission and should 
not be denied this life-saving therapy. 
~ Sfaut Assisted Direct Bal loon for Angioplasty 
Acute Myocardial Inforction, Prospective Trial 
Yashibisa Nakagawa, Hlreyoshi Yokoi, Hideyuki Nosaka, Hirsatsu Yokoi, 
Naoya Hmnasaki, Takashi Ktmura, Masaklyo NobuyoshL Kitakyushu, 
Kokura Memorial Hospital, Japan 
Thrembus formation is ~gnificant in the pathogenesls of AMI, and thrsmbus 
containing lesions have been considered to be contraindication for stenting. 
Acute reoccfuslon(AR) in CCU and silent closure($C) are major problems of 
Direct Balloon Angioplasty (DBA). From ,~=p. 1994 to June 1995, AMI patients 
(pts) under 80 years of age wore prospectively treated with now aggressive 
strategy of "Stent assisted DBA'. DBA was attempted in all AMI pts within 
12 hours of onset, except LMT infarction and cardiogenic shock. When the 
results of ,3BA was unsatisfactory and vessel size was > 3.0 ram, stent 
imptante.tion was performed subsequently. After stonflng, 3 days Hep~.rin, 
Aspirin ar¢l Coumadin were administrated as an ordinary anticoagulation 
regimen. Of the 111 pts (M/F = 92/19, age 62.4-11) ITeatsd with this protocol, 
85 pts(77%) received only DBA and 63 pts(97,6%) achieved succeesful 
repeduslon. In two pt~, DBA was failed due to massive thrembus. The rest of 
29 pts (28%) received successful etent implantation after subsptimol result 
of DBA. So overall successful reperfusion rate was 83 + 26/111 - 98,2%. 
AR In CCU occurred in 2 pts(2,3%) after DBA and subacufa thrombosis 
of stem occurred in 2 pts(7,7%). These 4 pts received repeat angiopiesty 
successfully. Two In-hospital death was documented(I.8%). Of the 109 pts 
dicharged alive, all pts received late anglogrephy(18 • 7 days). It revealed 
1 SC after DBA and there was no $C with stent, so overall late patenoy 
rate was 108/109 = 99.1%. In conclusion, stenting for suboptimal DBA had 
favorable effect to restore and sustain pataney and prevent AR and SC, 
"Sfant assisted DBA" is considered to be feasible and effective strategy for 
AMI. Further angiegraphl¢ follow up study is ongoing. 
~ Early BIo©hemlcal Markers In Bahaviour of  
Patlenls With TIMI Grade 2 Flow In the 
Infarct-Related Artery 90 Min After Thrombolysis 
for  Acute Myocardisl Inforction 
Thierry Laperche, R Gabriel Steg, PERM Study Group, France 
Dudng acute myocardial infarction (MI), Its with TIMI grade 2 flow in the 
infarct vessel have a worse prognosis than Pts with TIMI 3 flow. While 
btoct~emical morkers have been suggested for the non-lnvaslve diagnosis of 
reperfuslon early after thrembolyals, its is important o discriminate Pts with 
T1MI grade 2 flow from Pts with TIMI grade 3 flow. 
97 Pts with acute MI _< 6 h, treated with thmmbelytics, all underwent 90 
rain angibgraphy to assess flow in the infarct-vassal (TIMI grade 0-1, TIMI 
2, TIMI 3). At the onset of thrembely.qls (tO) and 90 min later (tgO), all had 
blood samples drawn to measure myoglobin (Myo), MM3/MM1 CK isoforms, 
Treponib T (l"nT) and CK-MB. The relative increase (RI = t~'~ - t0/to) over 
90 minutes were ¢P,;=ulated in each group. For all the mark~.~, studied, the 
moan to -and toO serum values were higher in TIMI 2 Its than in TIM', 3 Pts 
(p < 0.05 for Myo). RI at tg0 were consistently (but not si~'~iflcantly) ower in 
TIMI 2 Pts than in TIMI 3 PIs. In Pfa treated > 3 h after the onset of pain, 
results of RI were: 
Myo MM3/MM1 TnT CK-MB 
TIMI 0-1 2,oKa- 4 1.1+1.5 10+ °0 2.4:1:2.6 
TIMI2 4.2+4.5 0.9+0.7 9+15 2.2+2.5 
TIMI3 28.5+34 *$ 10.5+17.8 110+317 10+16 
°p < 0.05 between TIM! 0-1 and TIMI 3, l;p < 0.05 between ~MI 2 and TIMI 3. 
In conclusien, in patients treated > 3 h after onset of pain, when biochem- 
ical markers are used Io estimate thfarct-related artery patency 90 min after 
thmmbolysis, indexes based on refative increase of myoglobin at 90 min tend 
to separate patients with TIMI 2 and 3 flow. 
~ Ischemla After Thrombolysis Is Frequent, 
Somewhat Predictable, and Pre-Empted by Early 
Angio~-,~phy 
Louise Pilote, Magnus hman, Dave P. Miller, Robert M. Catiff, EdcJ. Topoi. 
GUSTO-I Investigatore, Cleveland Clinic Foundation, Cleveland, OH 
To identify predictors of recurrent isohemia after thrembelysis and to inves- 
tigate the relationship between ischemia and coronary engiography (anoio), 
we examined the GUSTO-I database. Of the 21,772 US GUSTO-I patients, 
6313 (29%) experienced ischemia before discharge. In a multiple Cox regres- 
sion, womon (RR: 1.25; 95% CI: 1.17-1.33), patients with high cholesterol 
(RR: 1.14; 95% CI: 1.07-1.22) and patients with prior angina (RR! 1.40; 95% 
Ch 1.32-1.49) had a higher likelihood of ischemia. Current smoking and time 
to thrombolysis were inversely related to ischemie (RR: 0.86; 95% CI: 0.81- 
0.92, RR: 0.97; 95% CI: 0.95-0.99, respectively). Patients who underwent 
angio had a slightly increased risk of ischemia in the 12 hours after angio 
(RFI: 1.2; 95% CI: 1.1-1.4), but ultimately, these patients had a considerably 
lower dsk 1 week after anglo than patients without anglo (RR: 0.56; 95% CI: 
0.45--0.72, Figure). 
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In conclusion, early anglo confers a net 44% reduction in ischemia at I 
week, probably h~,me high risk patients are idenf~ed and mvascuterized. 
~ A  Prospective, Randomized, Control led Study of  
Warfadn Plus Aspir in to Prevent Coronary 
Reoc~luslon After Thrombolysls 
Giovanni Melandfi, Nicolat~ Candlotfl, Fmnco Sempdnl, Vittodo Cervi, 
Latizia Baschl Regglenl, Angefo Bran:,; Bruno MagnanL Institute of 
Cardiology, University of Bofogr~ Italy 
Aspirin (A) and warfarin ON) are poor agents in the prevention of coronary 
(re)cocIuslon after thrombelysie. Since platelefs and thrombin are beth impar- 
tent mediators of coronary (,'e)thmmhosie we randomized 65 pts to receive 
either A (160 mg daily) or A (same dosage) plus W (target INR 2.5 to 3.5) 
after thrembelysis (front-loaded rt-PA). 
Coronary engiogrephy was performed within one week and after three 
months. The INR in the A + W group was 2.7 =: 0.7 at one month, 2.5:1: 
0.9 at two months and 2.5 • 0.6 at three months. 48% INR values were 
therapeutic, 46% subtherapeuflc -',nd 6% supmthempeu~c. The two groups 
did not differ in age, sex, site of infalction, risk factors. In the group ~eated 
with A + W we obselved a decrease in the overall % stenosis (74 ± 26 to 66 
29, p = 0.028) and in culprit vessel % stenosts (82 :l: 14 to 74 ± 24, p = 
0,07). In the A group changes were insignificant (66 ± 28 to 63 ± 29, p = NS 
and 77 ± 17 1O 83:1: 23, p = NS, mspacfivefy). In the A + W group the culprit 
vessel % sfanosis was improved in 43%, unchanged in 36% and worsened 
in 21%, In the A group the figures wore 8%, 36% and 56% respectively (p 
= 0.0001). When all vessels were considered, again, there was a'benofit in 
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the A+W group (39°/o, 12%, 19% ve 22%, 39% and 33%, p - 0.003). 20 A 
lots vs only 4 A + W pts showed angina p~=:ctoris in the follow up (p = 0.011), 
while them was no significant difference in the occurrence of other morbid 
events. Thus, we conclude that A + W leads to a more fevourable mmodellng 
of the comnmy tree after thmmbelysis, fadlitating thmmbus regression and 
improving angina symptoms. The effects on other clinical events should be 
investigated in a large trial. 
~ The Value o f  Immediate Coronary Anglography 
With Primary PTCA Standby In the Trtage and 
Treatment of  Acute Myocardial Infaratlon at 
Cemmunlty Hospitals Without Heart Surgery: 
Experience In 305 Cases 
Thomas R Wharton, Nancy S. McNamara, James M. Schmitz, Frank 
A. Fedele, Alan R. Gladstone, Mad~ I. Jacobs. Exeter Hospital, Exeter, NH 
Recent studies support the value of immediate coronary angtography in risk 
stratification and triage of patients with acute myocardial infarction [AMI]. 
Early knowledge of coronary anatomy can identify patients Lots] at high dsk 
who require early bypass surgery, and can spore unnecessary thmmbelytic 
therapy in pfs who have patent vessels after aspirin and hepadn, oaclusion 
of minor branches, or mistaken diagnosis. These benefits may enhance the 
therapeutic value of primary PTCA. We examined the outcomes of immedi- 
ate coronary angiography in 305 consecutive pts with suspected AMI who 
undensent emergent cath with PTCA standby at two community hospitals 
without on-slte bypass surgery. CHF was present in 3"P/o, 15% presented in 
shock, and 9% in ventdcular fibrillation. Only 25% were "tow-risk" (age < 70, 
EF > 45°/o, 1-2 vessel disease); 36°/= were > 65 yo; 31% were women. 
Results: PTCA was performed in 217 pts {71%). Procedure success rate 
was 94%, median time to repertusion 93 rain, reocclusion rate 6%, minfarclion 
rate 3.7%, in-hospital mortality 6.8% (2.9% in non-shock pts). No pt needed 
emergency CABG because of PTCA complications. Patent artedas (TIMI-3 
flow) were not dilated. Of the 88 pts who did not have PTCA, 81 (27% of 
the entire group) would not have benef'~d from tytic therapy: the artery was 
potent on the first anglogram in 50 pts and was a small or secondary vessel 
in 4; the diagnosis of AMI was discovered to be incorrect in 12, and 15 
had llfe-threatenlng coronary anatomy that required immediate transfer (with 
IABP) for bypass surgery. 30% had bypass surgery within 24 h. Another 6 had 
lesions unsuitable for PTCA; intracomnary urokinase achieved potency in 3 
of these. The in-hospital mortality of this no-PTCA group was 1.1%, including 
surgery. The entire cohort of 305 patients had an in-hospital mortality rate of 
3.4% (shock mortality 22%, non-shock mortality 2.0%). 
Conclusion: Immediate catheterization with PTCA standby in suspected 
AMI can be performed s=~tely and effectively in community hospitals without 
cardiac surgery. Initial anglography enabled informed therapeutic decisions, 
including early selection of highest risk pto for bypass surgery and avoidance 
of the risk and expense of lyrics in an important fraction of the population. 
~ Cardiogenlc Shock After Acute I~jocardlal  
Infarction: Successful Bridge to Transplantation 
With the Implantable Left Ventrlcular Assist OevIce 
Nicholas G. Smedim, Amit N. Petal, Rite Vargo, Robert E. Hobbs, James 
B. Young, Patrick M. McCarthy. Cleveland Clinic Foundation, Cleveland, 
Ohio. 
Acute myocardial infarction (AMI) complicated by cardlogentc shock is fre- 
quently fatal. In this setting, implanting LVADS as a bridge to transplantation 
is thought o be contraindicated because of small LV chamber size and friable 
myocardial tissue. From December, f992 to July, 1995, 9 petlems in cardlo- 
genlc shock at a mean of 6 days after an AMI received a HeartMate LVAD. 
The mean patient age was 49 yrs and 5 (55%) were female. Large anterior 
or anterior-lateral infarctions were present in all pto; 4 (44%) required CPR, 8 
(89%) were on an IABP and 3 (33%) were supported by ECMO. Satisfactory 
LVAO inflow cannula position was ccnflrmed by Inl~opemtive TEE In all pts. 
Them were no bleeding ccmpliceflons or ventrlcular disruptions econdary 
to LV apioal cannuiotlon. One pt with RV failure required RVAD support and 
two pt¢ with severe pulmonary edema were managed by vane-vane ECMO 
(1 pt) and RVAD-ECMO (1 lot). Hemodynamlco improved oigniticantly in all 
pts. 
Pre-LVAD PoSt-LVAD p Value 
CI (Uminlm 2) 1.8 4- 0.43 2.9 + 0.68 0.002 
LAP (rnmHg) 22 4- 5.1 13 it: 3.4 0.008 
RVEF (%) 224. 5.0 38 4-11 0.031 
Eight lots (65%0) survived and were discharged from the ICU at a mean of 
8 days (range:3-30). The one death from multiple organ failure and all major 
complications occurred In pts who had pre.LVAD CPR and needed an RVAD 
or ECMO. All lots warn in NYHA FC I or II before transplant after a mean of 
97 days (range:39-144) of support. All transplanted patients am alive. We 
believe the Imptonfable LVAD can be used to treat cardtogenlc shock after 
an AMI in young moribund patients provided that support is initiated before 
other organ injury. 
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~ " ]  RECPAM (RECumlve Partit ion and AMalgamation), 
• Novel Statistical Approach for Early Prediction of 
Outcome In Patients With Acute Myocardial 
Infarction 
Fabrizlo Cadncl, Claudio Fresco, Aide P. Maggioni, Antonio Nicclucci, 
MariaGrazia Franzosi, Gianni TognonL M. Negri Institute, Milano and $. 
Maria Imbaro, #a/y 
Aim of this study was to avaluata the ability of a new statistical approach to 
predict in-hospital outcome in pts with acute myocardial infarction (AMI). In pts 
enrolled to GISS(-2 study all the variables available at admission to CCU were 
used. In-hospital mort,,Jity was chosen as end-point. This method identifies 
homogeneous and disdnct subgroups with respect to pre-spaclfled cdteda. 
The algorhythm ~ubdividas the population using the vaflables in a hierarchical 
approach, iden:itying for evanj division the variable and the cut oft that most 
efficlan~<y cm3',es two subgroups with different outcome rate. The terminal 
subgroups a~e successively merged to create a set of classes statistically 
distinct with mspeot to the primary end-point. The following variables were 
submitted to the RECPAM algorhythm: infamtion site, KI111p class, smoking 
habit, history of previous MI, hypercholestemlemia, hypertension, diabetes° 
age, gender, heart rate, blood pressure, familiar history of MI. 
A total of 15 terminal subgmupo were identified. In the lowest risk subgroup 
4 events out of 1116 pts were recorded, while in the highest risk subgroup 
226 events were recorded in 438 pts. After the amalgamation step RECPAM 
identified 7 classes with stetis'~:ally different mortality. Compared with the 
lowest dsk class° the six classes had an odd rang of 5A (95%CI 3.0-9.8), 13.8 
(g5%CI 7.6-25.3), 22.0 (65%CI 12.0-40.2), 44.9 (95%CI 25.1-80.2), g1.5 
(95% 50.7-165.0) and 208.6 (95%CI 114.8-379.0) respectively. In porfloular 
throe subgroups in Killip 1 class had a statistically significant worse prognosis 
compared to one subgroup of pts who presented with Killlp class 2 at enW. 
In conclusion, RECPAM, using a tree structured algerbythm, was able to 
identify very efficiently the in-hospital prognosis of lots with AM( from the 
available variables at CCU entry. 
I 974-55 1 Centralized Systematic Adjudication of  Clinical 
Endpoints In Multicanter Trials o f  Acute Coronary 
Syndromes Identil les Patients At High Risk for  
Adverse Clinical Outcomes 
Kenneth W. Mahaffey, Christopher B. Granger, Lynn WoodUef, Bad)are 
E. Tardifi, Shirley B~tndy, Robert M. Califf. Duke Unlvemity Medical Center, 
Durham, NC 
A centralized Clinical Events Committee (CEC) adjudicated suspected re- 
infamtions (reMI) that were identified by computerized •ggem applied to 
case rupert form date in the GUSTO.Ila trial. We compared the clinlcal 
outcomes for patients with suspected reMI about whom the CEC and inves- 
tigator agreed them was a mMI and for patients about whom the CEC and 
investigator disagreed them was a mMI with the following results: 
Outcome Agreements Disagreements 
Both 'No' Both 'Yes' CEC 'Yes' CEC 'No' 
30-clay Death 15 (7%) 20 (20%) 4 (13%) 14 (24%) 
Recurrent Angina 61 {31%) 80 (80%) 13 (43%) 80 (64%) 
Heart Failure 22 (11%) 28 (20%) 4 (13%) g (15%) 
Shock 14(7%) 21 (21%) 1 (3%) 9 (15%) 
TOtal Patients* 195 100 30 59 
"Not all patients with reMI had one of these outcome vents. 
The CEC and investigator disagreed in 23% of the cases with suspected 
mML When beth agreed that mMI occurred, patients with mMI had higher 
ratee of adverse outcomes compared with patients ~thout mMI. For cases 
with disagreements, the CEC Identified 36 cases meeting the definition for 
mMI that had intermediate rates for edveme events. The thvestigetem idan- 
tilled 5 ° additional mMIs not meeting strict criteria used by the CEC for mMI 
but associated with a high incidence of adverse outcomes. 
